Hormonal Therapy for Prostate Cancer
- 15 November 1984
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 311 (20) , 1313-1314
- https://doi.org/10.1056/nejm198411153112010
Abstract
Most patients with a diagnosis of prostate cancer already have metastases or will have them despite treatment aimed at the primary tumor in the prostate gland. The axial skeleton is the predominant site of dissemination; bone pain is the usual source of the patient's discomfort and debility. Although symptomatic relief is always temporary and sometimes incomplete, hormonal treatments can palliate the symptoms in the majority of patients, making prostatic cancer the tumor most responsive to hormonal therapy.Reduction of serum testosterone levels is a common feature of effective hormonal therapy in this disease. It can be achieved with orchiectomy, with . . .Keywords
This publication has 6 references indexed in Scilit:
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapyCancer, 1984
- Pre-Estrogen Breast Irradiation for Patients with Carcinoma of the Prostate: A Critical ReviewJournal of Urology, 1979
- A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen-treated responsive and refractory human prostatic carcinomaCancer, 1977
- Estrogen Dosage and Suppression of Testosterone Levels in Patients with Prostatic CarcinomaJournal of Urology, 1973
- Carcinoma of the Prostate: Treatment ComparisonsJournal of Urology, 1967